MétaCan
Menu
← Back to cohort
Record W2913628329 · doi:10.1093/ecco-jcc/jjy222.591

P467 Circulating CD8 α4β7+ and CD8b7+ memory T cells as early biomarkers of clinical response to vedolizumab in ulcerative colitis

2019· article· en· W2913628329 on OpenAlexaboutno aff
M González-Vivó, M K Lund Tiirikainen, Chernitskiĭ Gi, Ester Ruiz‐Romeu, Laia Sans, Lidia Canillas, Montserrat Andreu, Luis F. Santamaria‐Babí, Lucía Márquez

Bibliographic record

VenueJournal of Crohn s and Colitis · 2019
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsnot available
Fundersnot available
KeywordsCalprotectinVedolizumabUlcerative colitisMedicineInternal medicineGastroenterologyBiomarkerCD8Faecal calprotectinImmunologyColitisInflammatory bowel diseaseDiseaseImmune systemBiology

Abstract

fetched live from OpenAlex

Vedolizumab (VDZ) is a humanised monoclonal antibody targeting the α4β7 integrin us in ulcerative colitis (UC). So far, no biomarker of response to VDZ has been identified. To assess whether circulating CD4+ and CD8+ α4β7+/ α4β7- memory T lymphocytes are molecular markers of response to VDZ treatment in patients with UC. Prospective study, 15 patients with active UC (Ulcerative Colitis Disease Activity Index (UCDAI) >3, Mayo endoscopic subscore >1, faecal calprotectin >250 μg/g) and with prior failure to anti-TNFα therapy, starting treatment with VDZ ( 300 mg iv, standard induction regime). Peripheral blood sample obtained just before first dose of VDZ, purification of circulating memory T cells (CD45RO+) and simultaneous analysis of CD CD4+ and CD8+ limphocitic subpopulations (α4β7+/−, HLA-DR+/−, CD25+/−, IL23R+/−, CCR9+/−, IL17A+/−, IL-23R+/−, IL-9+/−, β7 +/−) by flow citometry. Clinical response and remission (UCDAI clínic) and faecal calprotectin levels were evaluated at Weeks 6 and 14. Eight females, age 46 ± 16 years extent (Montreal E1: 2 patients, E2: 8 patients, and E3: 5 patients), 7 severe colitis (UCDAI > 9). At Week 6: 9 patients were in clinical response, 7 patients were in clinical remission and 8 patients had faecal calprotectin levels <250 μg/g. At Week 14 : 10 patients remained in clinical response , 8 were in clinical remission and 10 patients had faecal calprotectin levels <250 μg/g. Patients with clinical response, clinical remission and faecal calprotectin levels < 250 μg/g at Week 6; and clinical remission and faecal calprotectin levels < 250 μg/g at Week 14, presented an absolute account of CD8 α4β7+ and CD8b7+ memory T cells at baseline significantly higher when compared with patients with no VDZ response (Table 1). No differences were identified according to the severity of the flare or the extent of the disease. No statistically significant differences were identified in the other lymphocyte subpopulations included in the study. The absolute account of CD8 α4β7+ and CD8b7+ memory T cells before starting VDZ treatment could be early biomarkers of clinical response, allowing to select a subset of patients that are more likely to respond to VDZ.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.011
GPT teacher head0.290
Teacher spread0.280 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Crohn s and Colitis→Same topicInflammatory Bowel Disease→French-language works237,207→